This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Review Which Crypto Strategies Are Low Risk, focusing on capital preservation, diversification, and disciplined rebalancing.
27,978 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
March's trading session brought a noticeable shift as airline stocks rallied amid easing fuel concerns. This piece br...
A single market signal suggests SpaceX's IPO could roar, but history warns investors not to blindly chase headlines. ...
The AI boom isn’t over. If you felt you missed the first wave, these three resilient stocks deliver real AI leverage,...
Investors are weighing Tilray and Trulieve to find the better marijuana stock right now. This guide breaks down funda...
MIAX is shaping 2026 in a dynamic way, and the first-quarter earnings transcript offers clues about growth drivers an...
Original Medicare covers your doctor bills after the deductible, but the 20% coinsurance has no cap. As costs rise, r...
As markets react to CODI's Q1 2026 results, the codi 2026 earnings call offers a clear view of growth drivers, profit...
Geopolitical tensions with Iran have rattled energy markets, sending LNG-focused stocks lower while underscoring long...
Visa just posted strongest growth in years, igniting the debate about a potential stock move. This article breaks dow...
As AI fuels data growth, Silicon Motion Technology stands out in the memory controller niche. This article breaks dow...